Skip to main content
Download PDF
- Main
Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of Integrated Clinic Systems Cohort
- Ma, Jimmy;
- Nance, Robin M;
- Delaney, Joseph AC;
- Whitney, Bridget M;
- Bamford, Laura;
- Gravett, Ronnie M;
- Moore, Richard D;
- Napravnik, Sonia;
- Mayer, Kenneth H;
- Jacobson, Jeffrey M;
- Christopoulos, Katerina;
- Burkholder, Greer A;
- Keruly, Jeanne;
- Eron, Joseph J;
- Martin, Jeffrey;
- Cachay, Edward R;
- Saag, Michael S;
- Crane, Heidi M;
- Kitahata, Mari M
- et al.
Published Web Location
https://doi.org/10.1093/cid/ciac086Abstract
Among 14 049 people with human immunodeficiency virus in care in 2019-2020, 96% were treated with antiretroviral therapy (ART). Current antiretroviral treatment patterns highlight high uptake of guideline-recommended ART regimens including second-generation integrase strand transfer inhibitors (dolutegravir and bictegravir) and tenofovir alafenamide, especially in antiretroviral-naive individuals initiating ART.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.